Home/Filings/4/0001628280-25-053812
4//SEC Filing

Juvenal Tobin W 4

Accession 0001628280-25-053812

CIK 0001447362other

Filed

Nov 23, 7:00 PM ET

Accepted

Nov 24, 4:24 PM ET

Size

10.1 KB

Accession

0001628280-25-053812

Insider Transaction Report

Form 4
Period: 2025-11-20
Juvenal Tobin W
Chief Commercial Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2025-11-20$3.38/sh+4,693$15,86289,288 total
  • Sale

    Common Stock

    2025-11-20$35.58/sh4,693$166,97784,595 total
  • Exercise/Conversion

    Stock option (right to buy)

    2025-11-204,69311,210 total
    Exercise: $3.38Exp: 2029-03-12Common Stock (4,693 underlying)
Holdings
  • Common Stock

    (indirect: By Trust)
    2,230
Footnotes (5)
  • [F1]This transaction was made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 11, 2024.
  • [F2]Reflects an adjustment of 68 shares to the number of shares beneficially owned following a reconciliation of the Reporting Person's records.
  • [F3]This transaction was executed in multiple trades at prices ranging from $35.40 to $35.85, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F4]Held by Tobin W and Susan M Juvenal Family Revocable Trust of which the Reporting Person and his spouse are the trustees and the Reporting Person, his spouse and their children are the beneficiaries.
  • [F5]The shares subject to the option are fully vested.

Issuer

CASTLE BIOSCIENCES INC

CIK 0001447362

Entity typeother

Related Parties

1
  • filerCIK 0001856542

Filing Metadata

Form type
4
Filed
Nov 23, 7:00 PM ET
Accepted
Nov 24, 4:24 PM ET
Size
10.1 KB